About
Arkion®Life Sciences

Modern Solutions to Today’s Problems

Arkion®Life Sciences is a technology based company that discovers, develops, manufactures and markets environmental friendly products and technology that provides modern solutions to today’s problems. From its beginning as a DuPont and ConAgra startup company, Arkion has combined the better attributes of the two.

Our Brands

In the process, Arkion has developed several breakthrough products for

Agriculture crop protection

Safe control of birds

Pest control for organic crops and orchards

Passive immunity products for animals and humans

First truly effective natural mosquito and tick control products

Our Company

Leader in the Field of Biotechnology

Arkion’s growth from a consortium startup company to a leader in the field of biotechnology is exemplary of what happens when a company gives individual people the opportunity to grow and cultivate their ideas.

Arkion Strives to Provide Tomorrow’s Innovative Solutions Today

Arkion Empowers

Creativity
Open Dialogue
Engagement
Learning Opportunities

Leadership

Dr. Earnest Porta

CEO

Dr. Porta obtained a B.S. in Chemical Engineering from Drexel Institute of Technology and went on to complete a Ph.D. in Chemical Engineering from Clarkson College of Technology. He then started his career working for DuPont in various management positions until becoming President and Managing Director of DCV, Inc in 1992.  When DVC Inc. formed Arkion in 2001, Dr. Porta took over the role of President and CEO, where he remains. 

Mr. Rick Stejskal

CFO

Mr. Stejskal has been with Arkion® Life Sciences as the CFO since its founding in 2001. Prior to that, he held a similar position as Vice President of Financial Operations with DCV. Before working with DVC, he served as Vice President-Controller of DuCoa, a DuPont ConAgra joint venture. Mr. Stejskal served in a number of audit, finance, and accounting positions. He holds a B.S. in Agricultural Economics and Business Administration from Kansas State University.

Mr. Ken Ballinger

Arkion®'s Agricultural Crop Business Manager

Mr. Ballinger is responsible for managing Arkion®‘s Agricultural Crop Business. He has been with Arkion® Life Sciences, since 1993 and has been responsible for developing the various uses for anthraquinone. Mr. Ballinger holds patents on FlightControl® PLUS and other uses of anthraquinone. He graduated from Bowdoin College with a B.S. in Biology. He received his MBA from Long Island University in Marketing. His previous business experience has been with Johnson & Johnson and DuPont in Healthcare Sales, Marketing Management, and Business Development.

Mr. Lanny Weaver

Vice President of Arkion® Life Sciences

Mr. Weaver became Vice President of Arkion® Life Sciences at its inception.  He held a similar position with DCV Inc. Prior to joining DVC, he was President of Weaver Associates, a management consulting business specializing in strategic business planning and marketing to the packaging industry. Mr. Weaver spent the majority of his career with E.I. DuPont De Nemours and Co. He retired from the position of Business Director of Packaging Resins and Films with worldwide responsibility for Sales, Manufacturing, and R&D. He received his B.S. in Cereal Chemistry from Florida State University.

Dr. Reinhardt Rosson

President of Bio-Technical Resources (BTR)

Dr. Rosson is the President of Bio-Technical Resources (BTR), a division of Arkion® Life Sciences that specializes in strain development and fermentation work. Prior to stepping into the role as president, Dr. Rosson worked with BTR for 30 years holding various managerial positions ranging from Vice President to head of Business Development. Dr. Rosson obtained his A.B. in bacteriology and Ph.D in microbiology from University of California, Los Angeles. He also performed his postdoctoral fellowship at University of California, San Diego and later became an Assistant professor at the University of Texas at Austin, and later the University of Wisconsin, Milwaukee. Dr. Rosson also successfully founded a startup biotechnology company, BioPhontonic, Inc., prior to joining BTR. 

Scroll to Top